Clinical trials

  • CPK850 for Retinitis pigmentosa (RLBP1-associated)
  • AMBRISENTAN for Pulmonary arterial hypertension
  • IPILIMUMAB for Thymoma (type B3) | Thymic carcinoma
  • IMETELSTAT SODIUM for Myelofibrosis
  • Adipose tissue-derived mesenchymal stromal/stem cells (AdMSC) for Critical limb ischemia
  • RUXOTEMITIDE for Malignant melanoma, resectable, stage III-IV
  • BELZUTIFAN for Von Hippel-Lindau disease-associated renal cell carcinoma
  • ABROCITINIB for Moderate-to-severe atopic dermatitis
  • N-TEC for Patellofemoral osteoarthritis | Knee osteoarthritis
  • VEDOLIZUMAB for Moderately to severely active Crohn's disease
  • TEBENTAFUSP for Metastatic uveal melanoma
  • DARUNAVIR for HIV-1 and hepatitis B virus (HBV) co-infection